Contact this trialFirst, we need to learn more about you.
Anti-Inflammatory Drug + Pain Challenge for Pain
Recruiting0 awardsPhase 1
Houston, Texas
This trial will study whether a new bio-signature (a range of pro- and anti-nociceptive IL-1 family cytokine activity) can predict pain and release of endogenous opioids in healthy subjects. Another objective is to see if an anti-inflammatory drug (minocycline) will reduce pain during the experimental, nociceptive pain challenge.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service